5 Buy-Rated Stocks with Latest Insider Purchases
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3,086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at $8.96 per share.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 26,800 | $62,176 | +1240% | 0% | |
2. | Citadel Investment Group Ken Griffin | 25,298 | $58,691 | +21% | 0% |
3. | Renaissance Technologies Jim Simons | 77,750 | $180,000 | +161% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.28 | 2,000 | 597,135 | 2024-04-10 | Filing | ||
$2.26 | 1,000 | 193,211 | 2024-04-10 | Filing | ||
$2.42 | 2,000 | 80,475 | 2024-04-08 | Filing | ||
$2.15 | 1,100 | 124,665 | 2024-04-05 | Filing | ||
$2.37 | 2,000 | 595,135 | 2024-04-05 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$9.64 | 6,200 | Director | 51,956 | 2021-04-01 | Filing | |
$9.42 | 8,000 | Director | 15,208 | 2021-03-29 | Filing | |
$9.60 | 10,350 | Director | 58,156 | 2021-03-29 | Filing | |
$11.25 | 24,959 | Officer | 32,294 | 2020-11-27 | Filing | |
$10.04 | 26,797 | Director | 6,411 | 2020-12-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 377,720 | $876,310 | 0% | |
2. | 87,398 | $202,763 | 0% | |
3. | 46,753 | $138,389 | 0.05% | |
4. | 56,983 | $132,231 | 0% | |
5. | 36,487 | $84,650 | 0.01% |